Department of Defense Funds Lonza’s PermaDerm for Clinical Trials

The U.S. Department of Defense recently awarded more than $18 million in funding to a unit of Lonza Group, Ltd. for the development and commercialization of the therapeutic candidate PermaDerm for the treatment of severe burns among U.S. troops and civilians.
CNBC